LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹133 Cr | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹101 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹88 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | 32.49 | |
| Mar2024 | ₹101 Cr | -0.54 | |
| Mar2023 | ₹101 Cr | 12.27 | |
| Mar2022 | ₹90 Cr | 2.13 | |
| Mar2021 | ₹88 Cr | - | |
Compare Total Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹131.2 Cr | -7.6% | -2.7% | -8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.7% | -0.3% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4% | 8.9% | 54.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 3.6% | -0.5% | 28.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.5% | 13.6% | 9.4% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 3.2% | 5% | -11.9% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -7.6% |
-2.7% |
-8.6% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses